Understanding how to control stem cell differentiation has been a pivotal pursuit in biomedical research. Recent findings highlight the significant role of RNA condensates, particularly P-bodies, in ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

"These RNAs seem to act like postal codes for gene repression," said Dr. Anuj K. Verma, lead author of the study. "They help direct the polycomb complex to precise chromatin neighborhoods where stress ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Remix), a clinical-stage biotechnology company developing small ...

Answer ALS today announced the full release of its comprehensive ALS clinical and multi-omics dataset, marking the culmination of a multi-year research program and a groundbreaking collaboration with ...

Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech / pharma companiesAddressing large and ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...